AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23291020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) alone
Number of subjects: 79
Study 23291020 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA and prednisolone
Number of subjects: 79
Study 23291020 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA and azathioprine
Number of subjects: 79
Study 20653294 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMath self‐regulation skills and coherence training program
Number of subjects: 38
Study 19047976 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 250 mg q.i.d., amoxicilline 1 gr b.i.d. and PPI standard dose (MAO)
Number of subjects: 171
Study 19047976 — intervention group
Group type: COMPARATOR
Intervention: Tinidazole 500 mg b.i.d., amoxicilline 1 gr b.i.d. and PPI standard dose (TAO)
Number of subjects: 171
Study 16077882 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular management of AAA
Number of subjects: 0
Study 16077882 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery
Number of subjects: 0
Study 12877415 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded resin composite restoration with cuspal coverage
Number of subjects: 40
Study 12877415 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded resin composite restoration without cuspal coverage
Number of subjects: 40
Study 12877415 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as the absence of cuspal coverage)
Number of subjects: 40
Study 11107885 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy efficacy studies
Number of subjects: 0
Study 11107885 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy effectiveness studies
Number of subjects: 0
Study 11107885 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique-focused research
Number of subjects: 0
Study 8756037 — intervention group
Group type: COMPARATOR
Intervention: Temporal(R)
Number of subjects: 7
Study 8756037 — intervention group
Group type: COMPARATOR
Intervention: Taver(R)
Number of subjects: 7
Study 8756037 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine Lincoln
Number of subjects: 7
Study 8756037 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegretol(R)
Number of subjects: 7
Study 1533022 — intervention group
Group type: EXPERIMENTAL
Intervention: Nafarelin acetate
Number of subjects: 42
Study 1533022 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide acetate
Number of subjects: 42
Study 2865120 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole monotherapy
Number of subjects: 52
Study 2865120 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cortisone, salazosulfapyridine and metronidazole
Number of subjects: 52
Study 2865120 — intervention group
Group type: COMPARATOR
Intervention: Cortisone and salazosulfapyridine
Number of subjects: 52
Study 29275068 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose octasulfate dressing
Number of subjects: 240
Study 29275068 — intervention group
Group type: COMPARATOR
Intervention: Control dressing
Number of subjects: 240
Study 27432821 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (990 mg twice daily) for 12 weeks
Number of subjects: 60
Study 27432821 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study 24393346 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour and chronotherapy intervention (Group A)
Number of subjects: 90
Study 24393346 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour intervention only (Group B)
Number of subjects: 90
Study 24393346 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 22433400 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking
Number of subjects: 68
Study 22433400 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study 20228983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole tablet (200 mg per day for 14 days)
Number of subjects: 30
Study 20228983 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketoconazole 2% in orabase (applied twice daily)
Number of subjects: 30
Study 20228983 — intervention group
Group type: COMPARATOR
Intervention: Comparison between ketoconazole tablet and topical ketoconazole
Number of subjects: 30
Study 18334581 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 39
Study 16518989 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency tonsillectomy
Number of subjects: 0
Study 16518989 — intervention group
Group type: COMPARATOR
Intervention: Conventional blunt dissection tonsillectomy
Number of subjects: 0
Study 12785457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 75 mg plus acetaminophen 650 mg
Number of subjects: 0
Study 12785457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen combination
Number of subjects: 0
Study 11872340 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (RT) at 20 Gray (Gy)/5 fractions
Number of subjects: 75
Study 9527091 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble vascular cell adhesion molecule-1 (VCAM-1)
Number of subjects: 23
Study 9527091 — intervention group
Group type: EXPERIMENTAL
Intervention: E-selectin
Number of subjects: 23
Study 8703648 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI) 100 mg
Number of subjects: 8
Study 8703648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8703648 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxamine
Number of subjects: 8
Study 8703648 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline
Number of subjects: 8
Study 8703648 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infusions and/or systemic treatments
Number of subjects: 8
Study 2088631 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluroshield sealant (2% NaF, 1% adhesion promoter)
Number of subjects: 82
Study 2088631 — intervention group
Group type: COMPARATOR
Intervention: Prisma-Shield sealant (non-fluoride containing)
Number of subjects: 82
Study 370109 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine hydrochloride (150 mg daily)
Number of subjects: 53
Study 370109 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (20 mg daily)
Number of subjects: 53
Study 6306060 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone (2 mg)
Number of subjects: 12
Study 6306060 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 12
Study 6306060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30001469 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (0, 400, 1000, 2000, or 4000 IU/d for 12 weeks)
Number of subjects: 324
Study 30001469 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 324
Study 26894422 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnosis
Number of subjects: 0
Study 26894422 — intervention group
Group type: COMPARATOR
Intervention: No intervention (basal condition)
Number of subjects: 0
Study 25521843 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 100
Study 25521843 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 22360623 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-SOA arrangements
Number of subjects: 0
Study 22360623 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant-SOA arrangements
Number of subjects: 0
Study 21029813 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 1659
Study 18547294 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg.kg(‐1))
Number of subjects: 43
Study 18547294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 15929962 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk test (6MWT)
Number of subjects: 78
Study 12678150 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine
Number of subjects: 70
Study 12678150 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 70
Study 10648337 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine 60 mg
Number of subjects: 60
Study 10648337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 8863084 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents with invisible conditions
Number of subjects: 36284
Study 8863084 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents with visible conditions
Number of subjects: 36284
Study 8863084 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents with chronic conditions
Number of subjects: 36284
Study 8863084 — intervention group
Group type: COMPARATOR
Intervention: Adolescents without chronic conditions (controls)
Number of subjects: 36284
Study 1737074 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light treatment (2000‐3000 lux)
Number of subjects: 51
Study 1737074 — intervention group
Group type: COMPARATOR
Intervention: Dim red light placebo control treatment
Number of subjects: 51
Study 6093524 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g once daily
Number of subjects: 110
Study 6093524 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin 1 g three times daily
Number of subjects: 110
Study 30666071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional MMR vaccine
Number of subjects: 60
Study 30666071 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline injection)
Number of subjects: 60
Study 29218667 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal cholecystectomy
Number of subjects: 90
Study 29218667 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy
Number of subjects: 90
Study 27027655 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg once-yearly infusions of zoledronic acid
Number of subjects: 7765
Study 27027655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7765
Study 23990605 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 1112
Study 23990605 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 1112
Study 22849427 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (QUET)
Number of subjects: 26
Study 22849427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 26
Study 19665818 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab/docetaxel
Number of subjects: 61
Study 19665818 — intervention group
Group type: COMPARATOR
Intervention: Placebo/docetaxel
Number of subjects: 61
Study 18503512 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 28
Study 18503512 — intervention group
Group type: COMPARATOR
Intervention: Control (Sleep at Home)
Number of subjects: 28
Study 15765222 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of IA-2A autoantibodies
Number of subjects: 2556
Study 15765222 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of IA-2A and GADA autoantibodies
Number of subjects: 2556
Study 15765222 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of IA-2betaA autoantibodies
Number of subjects: 2556
Study 12443576 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine therapy plus anisodamine
Number of subjects: 90
Study 12443576 — intervention group
Group type: COMPARATOR
Intervention: Routine therapy only
Number of subjects: 90
Study 10546304 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming without water protection (Group I)
Number of subjects: 86
Study 10546304 — intervention group
Group type: COMPARATOR
Intervention: Swimming with water protection (Group II)
Number of subjects: 86
Study 8652322 — intervention group
Group type: EXPERIMENTAL
Intervention: Bair Hugger blanket on high setting
Number of subjects: 20
Study 8652322 — intervention group
Group type: COMPARATOR
Intervention: Control group (aluminized plastic 'space' blanket)
Number of subjects: 20
Study 1855280 — intervention group
Group type: EXPERIMENTAL
Intervention: batanopride
Number of subjects: 21
Study 1855280 — intervention group
Group type: COMPARATOR
Intervention: metoclopramide
Number of subjects: 21
Study 6749701 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoaminile citrate (40 mg, 3 x daily)
Number of subjects: 66
Study 6749701 — intervention group
Group type: COMPARATOR
Intervention: Chlophedianol hydrochloride (20 mg, 3 x daily)
Number of subjects: 66
Study 6749701 — intervention group
Group type: COMPARATOR
Intervention: Chlophedianol hydrochloride (20 mg)
Number of subjects: 66
Study 6749701 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoaminile citrate (40 mg)
Number of subjects: 66
Study 30092772 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin care by mother (kangaroo care) plus tactile-kinesthetic stimulation by mothers from randomization until hospital discharge, followed by a program of early intervention with 10 parents' orientation and 10 home visits.
Number of subjects: 0
Study 30092772 — intervention group
Group type: COMPARATOR
Intervention: Standard care according to the routine care of the NICU.
Number of subjects: 0
Study 27724972 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp Acupuncture (SA)
Number of subjects: 60
Study 27724972 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Number of subjects: 60
Study 27724972 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp Acupuncture and Electromagnetic Convergence Stimulation (SAEM-CS)
Number of subjects: 60
Study 27724972 — intervention group
Group type: COMPARATOR
Intervention: Conventional Stroke Rehabilitation (Control)
Number of subjects: 60
Study 25716730 — intervention group
Group type: EXPERIMENTAL
Intervention: MMSC infusion after allo-BMT
Number of subjects: 77
Study 25716730 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylaxis of aGVHD
Number of subjects: 77
Study 24429864 — intervention group
Group type: EXPERIMENTAL
Intervention: Kombinil-Duo ear drops
Number of subjects: 55
Study 24429864 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods
Number of subjects: 55
Study 19823880 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 54
Study 19823880 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasonic debridement (UST)
Number of subjects: 54
Study 17973163 — intervention group
Group type: EXPERIMENTAL
Intervention: TOGa system (transoral gastroplasty)
Number of subjects: 21
Study 16054579 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic block-randomization algorithm
Number of subjects: 0
Study 16054579 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 14559411 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological task instruction
Number of subjects: 48
Study 14559411 — intervention group
Group type: EXPERIMENTAL
Intervention: On-product information (OPI)
Number of subjects: 48
Study 14559411 — intervention group
Group type: EXPERIMENTAL
Intervention: Kettle design
Number of subjects: 48
Study 14559411 — intervention group
Group type: EXPERIMENTAL
Intervention: User variables (habits, environmental concern, control beliefs)
Number of subjects: 48
Study 14559411 — intervention group
Group type: EXPERIMENTAL
Intervention: User variable (knowledge)
Number of subjects: 48
Study 10539815 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 6758
Study 10539815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6758
Study 10539815 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (enalapril and placebo)
Number of subjects: 6758
Study 9345432 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical examination of spasticity
Number of subjects: 35
Study 9345432 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon reflex score
Number of subjects: 35
Study 1866755 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dextromethorphan (60 mg q.i.d.) for 3 weeks
Number of subjects: 10
Study 1866755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6629289 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric weight reduction diets
Number of subjects: 40
Study 30456899 — intervention group
Group type: EXPERIMENTAL
Intervention: IqYmune®
Number of subjects: 22
Study 30456899 — intervention group
Group type: COMPARATOR
Intervention: Kiovig®
Number of subjects: 22
Study 29497826 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 70
Study 29497826 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 70
Study 25875959 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel commissioning of NHS stop smoking services with payment for quits achieved.
Number of subjects: 2138947
Study 25875959 — intervention group
Group type: COMPARATOR
Intervention: Control group of PCTs without novel commissioning arrangements.
Number of subjects: 2138947
Study 25875959 — intervention group
Group type: EXPERIMENTAL
Intervention: Largest two providers in intervention PCTs.
Number of subjects: 2138947
Study 25875959 — intervention group
Group type: EXPERIMENTAL
Intervention: New market entrants in intervention PCTs.
Number of subjects: 2138947
Study 23525797 — intervention group
Group type: EXPERIMENTAL
Intervention: TP53 mutations
Number of subjects: 457
Study 23525797 — intervention group
Group type: EXPERIMENTAL
Intervention: del17p
Number of subjects: 457
Study 23525797 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete disruption of TP53 function (combination of point mutations and/or del17p)
Number of subjects: 457
Study 23525797 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterozygous TP53 mutation
Number of subjects: 457
Study 23525797 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete loss of TP53 function
Number of subjects: 457
Study 21737827 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 8
Study 21737827 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase
Number of subjects: 8
Study 19698011 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with losartan 50 mg and hydrochlorothiazide 12.5 mg/day
Number of subjects: 60
Study 19698011 — intervention group
Group type: COMPARATOR
Intervention: Losartan 100 mg/day (control group)
Number of subjects: 60
Study 17294322 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 84
Study 14973803 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure treatment (n = 75)
Number of subjects: 152
Study 14973803 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 77)
Number of subjects: 152
Study 11443510 — intervention group
Group type: EXPERIMENTAL
Intervention: Light work-related physical activity
Number of subjects: 2488
Study 11443510 — intervention group
Group type: EXPERIMENTAL
Intervention: Low physical activity
Number of subjects: 2488
Study 11443510 — intervention group
Group type: COMPARATOR
Intervention: Baseline energy intake, physical activity at work, alcohol consumption, smoking status
Number of subjects: 2488
Study 11443510 — intervention group
Group type: COMPARATOR
Intervention: Control variables (baseline weight, weight status, height, age, residence, income, educational attainment)
Number of subjects: 2488
Study 9619146 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 75
Study 9619146 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 75
Study 7605702 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteocalcin (Oc) levels in women with hip fracture
Number of subjects: 58
Study 7605702 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP) levels in women with hip fracture
Number of subjects: 58
Study 2123042 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention by phone
Number of subjects: 0
Study 2123042 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention by home visit
Number of subjects: 0
Study 2123042 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention by doctor in office
Number of subjects: 0
Study 2123042 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 324488 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol (1-(o-allyloxy-phenoxy)-3-isopropylamino-propan-2-ol hydrochloride)
Number of subjects: 0
Study 324488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31991236 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term exposure to nitrogen dioxide (NO2)
Number of subjects: 5485
Study 31991236 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term exposure to ozone (O3)
Number of subjects: 5485
Study 31991236 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term exposure to fine particulate matter (PM2.5)
Number of subjects: 5485
Study 31991236 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian Kernel machine regression (BKMR)
Number of subjects: 5485
Study 31991236 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression models
Number of subjects: 5485
Study 31178422 — intervention group
Group type: EXPERIMENTAL
Intervention: macitentan 10 mg once daily
Number of subjects: 85
Study 31178422 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 85
Study 25415393 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation application and conventional physiotherapy (group A)
Number of subjects: 28
Study 25415393 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy alone (group B)
Number of subjects: 28
Study 22336903 — intervention group
Group type: EXPERIMENTAL
Intervention: 640 mg anthocyanins daily
Number of subjects: 31
Study 22336903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 22132138 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided propofol infusion titrated to a BIS level of 65-75
Number of subjects: 500
Study 22132138 — intervention group
Group type: COMPARATOR
Intervention: Incremental midazolam bolus based on clinical judgment
Number of subjects: 500
Study 18654005 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase III cardiac rehabilitation program (exercise training, diet therapy, and weekly counseling for 6 months)
Number of subjects: 34
Study 18654005 — intervention group
Group type: COMPARATOR
Intervention: Usual outpatient care
Number of subjects: 34